Lenalidomide 10MG and 20MG
Ended Awarded
- Contract number
- 36C26126N0237
- Awardee
-
Exelan Pharmaceuticals Inc. UEI FYZXNHSQTMG8
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $29,090
Award facts
- Contract value 100% obligated
- $29,090.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Boca Raton, FL 33432, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21, awarded a $29,090.18 firm fixed-price delivery order to Exelan Pharmaceuticals Inc. for the supply of Lenalidomide 10mg and 20mg tablets. The contract, which carries an ultimate completion date of February 3, 2026, was awarded on December 3, 2025, with no set-aside designation. Performance will be executed at Exelan's facility in Boca Raton, Florida. This delivery order falls under the GSA Federal Supply Schedule Pharmaceuticals and Drugs contract (FSS-61-IB), enabling the VA to procure pharmaceutical products through established federal contracting vehicles.
Exelan Pharmaceuticals Inc. is a foreign-owned pharmaceutical company specializing in manufacturing, repackaging, and distributing generic and branded pharmaceutical products to federal healthcare systems. The company maintains a strong track record of supplying the VA, Department of Defense, Bureau of Prisons, and Indian Health Service through multiple federal contract vehicles and holds an active System for Award Management registration through July 30, 2026. Lenalidomide, an immunomodulatory agent used in cancer treatment and multiple myeloma therapy, represents a critical pharmaceutical supply for VA medical facilities. This delivery order exemplifies Exelan's role as a key pharmaceutical supplier supporting the VA's healthcare mission through competitive procurement mechanisms.
Quick answers
Who was awarded contract 36C26126N0237?
36C26126N0237 was awarded to Exelan Pharmaceuticals Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on December 3, 2025.
How much is contract 36C26126N0237 worth?
The government has obligated $29,090 on 36C26126N0237.
Is contract 36C26126N0237 an order under another contract?
Yes. 36C26126N0237 is a delivery order under 36F79720D0227, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26126N0237 competed?
The extent of competition for 36C26126N0237 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award